Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells

Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells

Saved in:

Bibliographic Details
Main Authors:	Luca Sala, Massimiliano Gnecchi, Peter J Schwartz
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2019-01-01
Series:	Arrhythmia & Electrophysiology Review
Online Access:	https://www.aerjournal.com/articles/Long-QT-Syndrome-Cardiomyocytes-Pluripotent-Stem-Cells
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A new hERG allosteric modulator rescues genetic and drug‐induced long‐QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells
by: Luca Sala, et al.
Published: (2016-07-01)

Human induced pluripotent stem cell derived nanovesicles for cardiomyocyte protection and proliferation
by: Yuhua Wei, et al.
Published: (2025-08-01)

Induced Pluripotent Stem Cells in Congenital Long QT Syndrome: Research Progress and Clinical Applications
by: Qing Li, et al.
Published: (2025-04-01)

Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes
by: Dao-Fu Dai, et al.
Published: (2017-01-01)

Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes
by: Renee G.C. Maas, et al.
Published: (2025-03-01)

Maturation of human induced pluripotent stem cell-derived cardiomyocytes promoted by Brachyury priming
by: Parisa K. Kargaran, et al.
Published: (2025-04-01)

Electrophysiological Changes of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes during Acute Hypoxia and Reoxygenation
by: Martta Häkli, et al.
Published: (2022-01-01)

Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients
by: Tadashi Takaki, et al.
Published: (2019-01-01)

NEXN deficiency leads to dilated cardiomyopathy in human pluripotent stem cell-derived cardiomyocytes
by: Mengqi Jiang, et al.
Published: (2025-07-01)

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling
by: Daniel R. Bayzigitov, et al.
Published: (2016-01-01)

Erratum to “Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients”
by: Tadashi Takaki, et al.
Published: (2020-01-01)

Protocol for dual-optical mapping of voltage and calcium sensors in human pluripotent stem cell-derived cardiomyocytes
by: Faisal J. Alibhai, et al.
Published: (2025-09-01)

Pro-Arrhythmic Effect of Chronic Stress-Associated Humoral Factors in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Shi Su, et al.
Published: (2025-06-01)

Supervised Machine Learning for Classification of the Electrophysiological Effects of Chronotropic Drugs on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
by: Christopher Heylman, et al.
Published: (2015-01-01)

Hypoxia and TNF‐alpha modulate extracellular vesicle release from human induced pluripotent stem cell‐derived cardiomyocytes
by: Margarida Viola, et al.
Published: (2024-11-01)

Structural and Mechanistic Bases of Nuclear Calcium Signaling in Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
by: Sen Li, et al.
Published: (2019-01-01)

Adipocyte-Mediated Electrophysiological Remodeling of PKP-2 Mutant Human Pluripotent Stem Cell-Derived Cardiomyocytes
by: Justin Morrissette-McAlmon, et al.
Published: (2024-11-01)

Establishment of a human-induced pluripotent stem cell line from a long QT syndrome type 2 patient harboring a KCNH2 mutation
by: Dasom Mun, et al.
Published: (2024-12-01)

Inhibition of ceramide synthesis improves the outcome of ischemia/reperfusion injury in cardiomyocytes derived from human induced pluripotent stem cell
by: Pellumb Haxhikadrija, et al.
Published: (2025-04-01)

Nanoplastics induces arrhythmia in human stem-cells derived cardiomyocytes
by: Shirley Pei Shan Chia, et al.
Published: (2025-01-01)

Integration of co-culture conditions and 3D gelatin methacryloyl hydrogels to improve human-induced pluripotent stem cells-derived cardiomyocytes maturation
by: Ilaria Gisone, et al.
Published: (2025-07-01)

A Platform Integrating Biophysical and Biochemical Stimuli to Enhance Differentiation and Maturation of Cardiomyocyte Subtypes Derived from Human Induced Pluripotent Stem Cells
by: Zhonggang Feng, et al.
Published: (2025-02-01)

Effects of Substrate Mechanics on Contractility of Cardiomyocytes Generated from Human Pluripotent Stem Cells
by: Laurie B. Hazeltine, et al.
Published: (2012-01-01)

Enhancing human pluripotent stem cell differentiation to cardiomyocytes through cardiac progenitor reseeding and cryopreservation
by: Austin K. Feeney, et al.
Published: (2025-05-01)

The identification of adenylyl cyclase modulators as potential receptors for 6-nitrodopamine in human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes and their relevance in heart inotropism
by: Irene Cipollone, et al.
Published: (2025-08-01)

Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype.
by: Junya Yokoyama, et al.
Published: (2021-01-01)

A Novel High-Content Screening-Based Method for Anti-Trypanosoma cruzi Drug Discovery Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Diogo Crispim Nascimento Portella, et al.
Published: (2021-01-01)

Clarithromycin-Induced Long QT Syndrome: A Case Report
by: Mecnun Cetin, et al.
Published: (2012-01-01)

3D-Printable Gelatin Methacrylate-Xanthan Gum Hydrogel Bioink Enabling Human Induced Pluripotent Stem Cell Differentiation into Cardiomyocytes
by: Virginia Deidda, et al.
Published: (2024-10-01)

Using diffusion tensor imaging to depict myocardial changes after matured pluripotent stem cell-derived cardiomyocyte transplantation
by: Moses P. Cook, et al.
Published: (2024-01-01)

Postpartum QT Prolongation in a Long QT Syndrome Type 1 Patient
by: Lilli C. Wiedenmann, et al.
Published: (2025-07-01)

Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis
by: Judith Cantó-Santos, et al.
Published: (2025-02-01)

LIFE-THREATENING MANIFEST OF LONG-QT-SYNDROME
by: M. E. Polyak, et al.
Published: (2014-05-01)

GENETIC ASPECTS OF CONGENITAL LONG QT SYNDROME
by: A. A. Chernova, et al.
Published: (2015-12-01)

Clinical Advances in Congenital Long QT Syndrome
by: Kun Li, et al.
Published: (2021-09-01)

Urine-Derived Induced Pluripotent Stem Cells in Cardiovascular Disease
by: Ping Huang, et al.
Published: (2020-01-01)

Drug-Induced QT Prolongation as a Result of an Escitalopram Overdose in a Patient with Previously Undiagnosed Congenital Long QT Syndrome
by: Paul Singh, et al.
Published: (2014-01-01)

Generation and Applications of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
by: Chengzhu Zhao, et al.
Published: (2018-01-01)

Generation of human induced pluripotent stem cell lines derived from two glucose transporter 1 deficiency syndrome patients
by: Rui Li, et al.
Published: (2024-12-01)

Effects of Propofol Treatment in Neural Progenitors Derived from Human-Induced Pluripotent Stem Cells
by: Bo Long, et al.
Published: (2017-01-01)